Any 0 3 0 3 O
previous 4 12 4 12 O
use 13 16 13 16 O
of 17 19 17 19 O
ARVs 20 24 20 24 B-treatment
with 25 29 25 29 O
the 30 33 30 33 O
exception 34 43 34 43 O
of 44 46 44 46 O
single 47 53 47 53 O
dose 54 58 54 58 O
NVP 59 62 59 62 B-treatment
( 63 64 63 64 O
Cohort 64 70 64 70 O
1 71 72 71 72 O
and 73 76 73 76 O
Cohort 77 83 77 83 O
2 84 85 84 85 O
) 85 86 85 86 O
or 87 89 87 89 O
up 90 92 90 92 O
to 93 95 93 95 O
6 96 97 96 97 B-upper_bound
weeks 98 103 98 103 I-upper_bound
of 104 106 104 106 O
AZT 107 110 107 110 B-treatment
( 111 112 111 112 O
Cohort 112 118 112 118 O
2 119 120 119 120 O
only 121 125 121 125 O
) 125 126 125 126 O
to 127 129 127 129 O
prevent 130 137 130 137 O
mother 138 144 138 144 O
- 144 145 144 145 O
to 145 147 145 147 O
- 147 148 147 148 O
child 148 153 148 153 O
transmission 154 166 154 166 O
( 167 168 167 168 O
MTCT 168 172 168 172 O
) 172 173 172 173 O

Documented 0 10 174 184 O
genotypic 11 20 185 194 O
evidence 21 29 195 203 O
of 30 32 204 206 O
non 33 36 207 210 B-treatment
- 36 37 210 211 I-treatment
nucleoside 37 47 211 221 I-treatment
reverse 48 55 222 229 I-treatment
transcriptase 56 69 230 243 I-treatment
inhibitor 70 79 244 253 I-treatment
( 80 81 254 255 I-treatment
NNRTI 81 86 255 260 I-treatment
) 86 87 260 261 I-treatment
resistance 88 98 262 272 O
at 99 101 273 275 O
screening 102 111 276 285 O
or 112 114 286 288 O
from 115 119 289 293 O
historical 120 130 294 304 O
data 131 135 305 309 O
available 136 145 310 319 O
in 146 148 320 322 O
the 149 152 323 326 O
source 153 159 327 333 O
documents 160 169 334 343 O

Has 0 3 344 347 O
diagnosed 4 13 348 357 O
with 14 18 358 362 O
documented 19 29 363 373 O
human 30 35 374 379 B-chronic_disease
immuno 36 42 380 386 I-chronic_disease
deficiency 43 53 387 397 I-chronic_disease
virus 54 59 398 403 I-chronic_disease
( 60 61 404 405 I-chronic_disease
HIV-1 61 66 405 410 I-chronic_disease
) 66 67 410 411 I-chronic_disease
infection 68 77 412 421 I-chronic_disease

Have 0 4 422 426 O
not 5 8 427 430 O
received 9 17 431 439 O
treatment 18 27 440 449 B-treatment
with 28 32 450 454 I-treatment
a 33 34 455 456 I-treatment
therapeutic 35 46 457 468 I-treatment
HIV 47 50 469 472 I-treatment
vaccine 51 58 473 480 I-treatment
or 59 61 481 483 I-treatment
an 62 64 484 486 I-treatment
HIV 65 68 487 490 I-treatment
drug 69 73 491 495 I-treatment
with 74 78 496 500 O
the 79 82 501 504 O
exception 83 92 505 514 O
of 93 95 515 517 O
a 96 97 518 519 O
single 98 104 520 526 O
dose 105 109 527 531 O
of 110 112 532 534 O
nevirapine 113 123 535 545 B-treatment
( 124 125 546 547 I-treatment
NVP 125 128 547 550 I-treatment
) 128 129 550 551 I-treatment
( 130 131 552 553 O
Cohort 131 137 553 559 O
1 138 139 560 561 O
and 140 143 562 565 O
Cohort 144 150 566 572 O
2 151 152 573 574 O
) 152 153 574 575 O
or 154 156 576 578 O
up 157 159 579 581 O
to 160 162 582 584 O
6 163 164 585 586 B-upper_bound
weeks 165 170 587 592 I-upper_bound
of 171 173 593 595 O
zidovudine 174 184 596 606 B-treatment
( 185 186 607 608 O
AZT 186 189 608 611 O
) 189 190 611 612 O
use 191 194 613 616 O
( 195 196 617 618 O
Cohort 196 202 618 624 O
2 203 204 625 626 O
only 205 209 627 631 O
) 209 210 631 632 O
prior 211 216 633 638 O
to 217 219 639 641 O
screening 220 229 642 651 O
to 230 232 652 654 O
prevent 233 240 655 662 O
mother 241 247 663 669 O
- 247 248 669 670 O
to 248 250 670 672 O
- 250 251 672 673 O
child 251 256 673 678 O
transmission 257 269 679 691 O

Must 0 4 692 696 O
have 5 9 697 701 O
HIV-1 10 15 702 707 B-chronic_disease
plasma 16 22 708 714 O
viral 23 28 715 720 O
load 29 33 721 725 O
at 34 36 726 728 O
screening 37 46 729 738 O
greater 47 54 739 746 O
than 55 59 747 751 O
equal 60 65 752 757 O
to 66 68 758 760 O
500 69 72 761 764 B-lower_bound
HIV-1 73 78 765 770 I-lower_bound
ribonucleic 79 90 771 782 I-lower_bound
acid 91 95 783 787 I-lower_bound
( 96 97 788 789 I-lower_bound
RNA 97 100 789 792 I-lower_bound
) 100 101 792 793 I-lower_bound
copies 102 108 794 800 I-lower_bound
/ 108 109 800 801 I-lower_bound
mL 109 111 801 803 I-lower_bound

Patient 0 7 804 811 O
has 8 11 812 815 O
active 12 18 816 822 B-chronic_disease
tuberculosis 19 31 823 835 I-chronic_disease
and/or 32 38 836 842 O
is 39 41 843 845 O
being 42 47 846 851 O
treated 48 55 852 859 O
for 56 59 860 863 O
tuberculosis 60 72 864 876 O
at 73 75 877 879 O
screening 76 85 880 889 O

Patient 0 7 890 897 O
has 8 11 898 901 O
any 12 15 902 905 O
currently 16 25 906 915 O
active 26 32 916 922 O
Acquired 33 41 923 931 B-chronic_disease
Immunodeficiency 42 58 932 948 I-chronic_disease
Syndrome 59 67 949 957 I-chronic_disease
( 68 69 958 959 I-chronic_disease
AIDS 69 73 959 963 I-chronic_disease
) 73 74 963 964 I-chronic_disease
defining 75 83 965 973 O
illness 84 91 974 981 O

Patients 0 8 982 990 O
who 9 12 991 994 O
meet 13 17 995 999 O
the 18 21 1000 1003 O
following 22 31 1004 1013 O
criteria 32 40 1014 1022 O
; 40 41 1022 1023 O
a 42 43 1024 1025 O
) 43 44 1025 1026 O
Cohort 45 51 1027 1033 O
1 52 53 1034 1035 O
: 53 54 1035 1036 O
Patients 55 63 1037 1045 O
Aged 64 68 1046 1050 B-age
greater 69 76 1051 1058 O
than 77 81 1059 1063 O
or 82 84 1064 1066 O
equal 85 90 1067 1072 O
to 91 93 1073 1075 O
( 94 95 1076 1077 O
> 95 96 1077 1078 O
=) 96 98 1078 1080 O
12 99 101 1081 1083 B-lower_bound
to 102 104 1084 1086 O
less 105 109 1087 1091 O
than 110 114 1092 1096 O
( 115 116 1097 1098 O
< 116 117 1098 1099 O
) 117 118 1099 1100 O
18 119 121 1101 1103 B-upper_bound
years 122 127 1104 1109 I-upper_bound
, 127 128 1109 1110 O
weight 129 135 1111 1117 B-clinical_variable
is 136 138 1118 1120 O
> 139 140 1121 1122 O
= 140 141 1122 1123 O
32 142 144 1124 1126 B-lower_bound
kilogram 145 153 1127 1135 I-lower_bound
( 154 155 1136 1137 I-lower_bound
kg 155 157 1137 1139 I-lower_bound
) 157 158 1139 1140 I-lower_bound
, 158 159 1140 1141 O
b 160 161 1142 1143 O
) 161 162 1143 1144 O
Cohort 163 169 1145 1151 O
2 170 171 1152 1153 O
; 171 172 1153 1154 O
Aged 173 177 1155 1159 O
> 178 179 1160 1161 O
= 179 180 1161 1162 O
6 181 182 1163 1164 B-lower_bound
to 183 185 1165 1167 O
< 186 187 1168 1169 O
12 188 190 1170 1172 B-upper_bound
years 191 196 1173 1178 I-upper_bound
, 196 197 1178 1179 O
weight 198 204 1180 1186 O
is 205 207 1187 1189 O
> 208 209 1190 1191 O
= 209 210 1191 1192 O
17 211 213 1193 1195 B-lower_bound
kg 214 216 1196 1198 I-lower_bound

Plasma 0 6 1199 1205 B-clinical_variable
viral 7 12 1206 1211 I-clinical_variable
load 13 17 1212 1216 I-clinical_variable
at 18 20 1217 1219 O
screening 21 30 1220 1229 O
greater 31 38 1230 1237 O
than 39 43 1238 1242 O
100,000 44 51 1243 1250 B-lower_bound
HIV-1 52 57 1251 1256 I-lower_bound
ribonucleic 58 69 1257 1268 I-lower_bound
acid 70 74 1269 1273 I-lower_bound
( 75 76 1274 1275 I-lower_bound
RNA 76 79 1275 1278 I-lower_bound
) 79 80 1278 1279 I-lower_bound
copies 81 87 1280 1286 I-lower_bound
/ 87 88 1286 1287 I-lower_bound
mL 88 90 1287 1289 I-lower_bound

Use 0 3 1290 1293 O
of 4 6 1294 1296 O
disallowed 7 17 1297 1307 O
concomitant 18 29 1308 1319 B-treatment
therapy 30 37 1320 1327 I-treatment
from 38 42 1328 1332 O
4 43 44 1333 1334 B-upper_bound
weeks 45 50 1335 1340 I-upper_bound
prior 51 56 1341 1346 I-upper_bound
to 57 59 1347 1349 O
the 60 63 1350 1353 O
baseline 64 72 1354 1362 O
visit 73 78 1363 1368 O

